DPx/Patheon Sells Biologics Facility … | Chemical & Engineering News
Volume 93 Issue 31 | p. 22 | Concentrates
Issue Date: August 3, 2015

DPx/Patheon Sells Biologics Facility …

Department: Business

Livia Group, a German investment company, will buy Patheon’s microbial fermentation facility in Capua, Italy. The plant has 1,400 m3 of capacity for manufacturing enzymes, therapeutic proteins, and small molecules. It serves customers in the food, feed, pharma, agrochemical, and fine chemicals industries. Patheon is a pharmaceutical contract manufacturer owned by U.S.-based DPx Holdings. It is preparing to launch as a public company.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment